|
|
||||||||
J Thorac Cardiovasc Surg 2007;134:649-656
© 2007 The American Association for Thoracic Surgery
Surgery for Acquired Cardiovascular Disease |
a Clinic for Cardiovascular Surgery, German Heart Center Munich, Munich, Germany
b Clinic for Cardiology, German Heart Center Munich, Munich, Germany
c Institute for Radiology, German Heart Center Munich, Munich, Germany
d Department for Internal Medicine I, Clinical Center Rosenheim, Munich, Germany.
Received for publication September 21, 2006; revisions received April 2, 2007; accepted for publication April 11, 2007. * Address for reprints: Sabine Bleiziffer, MD, Clinic for Cardiovascular Surgery, German Heart Center Munich, Lazarettstr. 36, 80636 Munich, Germany. (Email: bleiziffer{at}dhm.mhn.de).
| Abstract |
|---|
|
|
|---|
Methods: In 50 patients who underwent endoscopic radial artery harvesting for coronary artery bypass grafting, 64-slice computed tomography, electrocardiography, and echocardiography were utilized to assess graft patency and left ventricle function at a 1-year follow-up. In addition, the influencing factors of radial artery graft patency were evaluated. Radial artery patency was compared with a control group from our database.
Results: Any patency of endoscopically harvested radial artery grafts was 78% (39/50) and perfect patency was 72% (36/50) 1 year after coronary revascularization. The implanting surgeon and graft harvester, patient factors, graft properties, medication, and target territory did not influence the patency rates of the radial artery graft. The only significant and strong parameter to predict perfect graft patency was the severity of the target vessel stenosis (P < .001). In patients with a target vessel stenosis of 90% or greater, radial artery graft patency was 90.3% (28/31). Patency rates of endoscopically (72%) and conventionally (74%) harvested radial arteries were not different (P = .822).
Conclusions: Patency rates 1 year after endoscopic radial artery harvesting are comparable to the open technique. On the basis of our results, we attempt to use the radial artery as a bypass graft only for target coronary arteries with 90% or greater stenosis. We recommend endoscopic harvesting as the technique of choice to harvest the radial artery.
| Introduction |
|---|
|
|
|---|
To evaluate the graft patency of the endoscopic technique, we consecutively followed up our first series of patients who underwent endoscopic RA harvesting.
| Materials and Methods |
|---|
|
|
|---|
Endoscopic Radial Artery Harvesting
The nondominant arm was chosen for RA harvesting. Preoperative Allen test and Doppler examination were routinely performed to confirm adequate ulnar blood flow.
The RA was harvested through a single 3-cm skin incision. This technique is performed with an endoscope inserted into a retractor and a harmonic scalpel for the dissection of the artery. Transection of the artery is carried out with a pre-tied Endoloop. A detailed description of the technique has been published.5
Antispasmodic prophylaxis was carried out by intravenous application of 6 to 12 µg diltiazem/kg/min starting during extracorporeal circulation and continuing for 24 hours after the operation. We also recommended the administration of amlodipine as an antispasmodic agent in an oral dose of 5 mg/d for 3 months after the operation.
Intraoperative Assessment
Assessment of the bypass grafts was carried out after weaning from cardiopulmonary bypass and establishment of stable hemodynamic conditions with a transit time flowmeter (Medi-Stim ASA, Oslo, Norway). Mean graft flow and pulsatility index (PI) were obtained directly from the flowmeter.
Assessment of the Target Vessel Stenosis
Data concerning the severity of the target vessel stenosis for bypass grafting were collected from the preoperative angiograph, from which native coronary artery stenosis was determined by visual assessment.
Multislice Computed Tomographic Angiographic Analysis
A computed tomographic angiographic scan is routinely performed 1 year after coronary artery bypass grafting. Contrast-enhanced computed tomographic angiographic data (Sensation 64 Cardiac, Siemens Medical Solutions, New York, NY) were acquired with the use of a spiral scan with 32 x 0.6-mm collimation, 330 ms gantry rotation, pitch of 0.2, and tube voltage at 120 kV. The scanning range included the entire course of venous grafts and the most proximal part of internal thoracic artery grafts at their subclavian origin, if these arterial grafts had been used for bypass surgery.
All bypass grafts were independently evaluated by 2 investigators who were aware of the initial coronary artery bypass grafting procedure. The investigators independently evaluated the contrast-enhanced MSCT scans by assessment of the axial slices, multiplanar reformations, and 3 thin-slab maximum intensity projections. Lumen narrowings were classified by the maximal luminal diameter stenosis seen in any plane. Because localized bypass stenoses were not seen in the present cohort, the bypass grafts were classified as perfectly patent, patent, or occluded. All patients signed an informed consent.
Echocardiographic Analysis
All echocardiographic examinations were performed by an experienced investigator. Echocardiographic scanning was carried out under resting conditions using an image Point Hx ultrasound system with a 2.5-MHz transducer (Hewlett-Packard, Palo Alto, Calif). Measurements of left ventricular dimensions were performed in the long parasternal axis. Left ventricular function and wall motion abnormalities were evaluated by visual assessment.6
Control Group
To compare RA graft patency rate after endoscopic harvest (ENDO group) with the conventional open technique (OPEN group), 50 patients who had undergone coronary artery bypass grafting with a conventionally harvested RA in the above-mentioned time period were randomly and retrospectively selected from our database and served as controls. The patient characteristics and type of grafts implanted in the ENDO and OPEN groups are summarized in Tables 1 and 2.
Assessment of the target vessel stenosis and antispasmodic prophylaxis were performed in the control group as described above. Assessment of bypass graft patency was performed by MSCT in 33 patients of the control group and by angiography in 17 patients who had been followed up in an external clinic.
|
|
We performed a logistic regression analysis for patency of the RA after endoscopic harvest. We used forward selection and the likelihood ratio test for model selection. Included were age, gender, and all variables with a P value less than .10 in the univariate tests. Because normal distribution and homogeneity of variances were not given, a P value of less than .01 was considered statistically significant. Data analysis was performed with the Statistical Package for the Social Sciences version 14.0.1 (SPSS Inc, Chicago, Ill).
| Results |
|---|
|
|
|---|
In both groups, no cardiac reoperations have been performed. One patient has hemiparesis caused by postoperative apoplexy (ENDO group), and 1 patient underwent lateral thoracotomy for postoperative hematothorax (ENDO group). In 5 patients, sternal revision was performed (ENDO: n = 1, OPEN: n = 4). In 1 patient of the OPEN group, postoperative rethoracotomy was performed because of bleeding. No reinterventions have been necessary on the RA harvesting site in the ENDO group, whereas 1 patient in the OPEN group underwent wound revision. The surgical and catheter interventions performed in this series are summarized in Table 3.
|
|
Echocardiographic and Electrocardiographic Results (ENDO Group)
A total of 47 of 50 patients are in sinus rhythm, and 2 patients have an implanted pacemaker. One patient has multiple premature ventricular complexes, but his bypass grafts are patent. In 39 patients, left ventricular function is normal. Wall motion abnormalities are evident in 11 patients (n = 2 anterior wall hypokinesia, n = 1 posterior wall hypokinesia, n = 1 lateral wall hypokinesia, n = 6 septal dyskinesia and n = 1 diastolic dysfunction). Among the patients with wall motion abnormalities, 2 had an occluded RA graft.
Factors Influencing Radial Artery Graft Patency (ENDO Group)
To reveal factors affecting perfect RA graft patency after endoscopic RA harvesting, we tested the influence of patient characteristics, graft properties, postoperative medication, and target vessel properties (Table 4). Logistic regression revealed the severity of the target vessel stenosis as the only parameter indicating a significant and strong correlation with the patency rate (P < .001) (Table 5). In the group of patients with a target vessel stenosis of 90% or greater, 28 of 31 grafts (90.3%) were patent. The patency rate was 2.1 times higher in patients with a target vessel stenosis of 90% or greater. Mean target vessel stenosis had been 88.6% ± 16% in all patients with a perfectly patent RA graft versus 72.9% ± 15% in patients with an occluded graft (P = .003). Grafts with a flow rate of less than 55 mL/min seem to be more prone for occlusion (a flow of < 55 mL/min occurred in 13/36 patent grafts vs 11/14 occluded grafts, P = .007). However, graft flow was not detected as a significant factor influencing RA graft patency in the analysis of variances. Apparently, the learning curve of the first cases had no influence on patency; among our first 20 cases, only 1 RA graft was occluded.
|
|
Consequences in Patients with Occluded Radial Artery Graft (ENDO Group)
Among 14 of 50 patients with an occluded RA graft, 11 had no clinical symptoms. We recommended an exercise electrocardiogram to those patients to identify potential ischemia. Only 4 patients followed the recommendation, and all showed no signs of ischemia during exercise. Three patients with an occluded RA graft had angina during exercise. These patients had a target vessel stenosis of 80% to 100%. One of these patients had undergone stent implantation into the right coronary artery (RCA) because his RITA bypass was also occluded, resulting in an improvement of his symptoms. One patient refused angiography, and 1 patient with an occluded RA-RCA graft underwent stent implantation into the RCA.
| Discussion |
|---|
|
|
|---|
Patency rates published in the literature range from 51.3% (204/398) after 1.6 ± 1.4 years8
to 99.0% (100/101) after 2.9 ± 2.3 years.9
Most studies lack a prospective randomized design and must be interpreted with caution.10
A prospective randomized study showed no superiority of the RA over the SV graft when anastomosed randomly to the largest available coronary artery.11
In contrast, the prospective randomized Radial Artery Patency Study trial showed a significantly lower occlusion rate for the RA versus the SV graft at 1-year angiography.4
A recent prospective randomized trial also showed superior patency of the RA (95%) over SV (79%) grafts at a 5-year follow up in 101 patients. In this study, all grafts were anastomosed to the circumflex territory with a target vessel stenosis greater than 75%.12
A recent review article from Manabe and Sunamori13
describes a graft patency of 78.5% when the RA was anastomosed to the left circumflex territory and of 74.1% when anastomosed to the RCA territory. These data are comparable to our results with perfect patency rates of 67% (left circumflex territory) and 80% (RCA territory) with an overall rate of any patency of 78% and a perfect patency rate of 72%. Concerning mortality after coronary artery bypass grafting, Zacharias and associates14
found a significantly better cumulative 0- to 6-year survival in patients with RA versus SV grafts.
To our knowledge, we are the first to describe a prospective investigation of the patency rate 1 year after endoscopic RA harvest in a cohort of 50 patients. Some studies report early results. Miles and colleagues15
describe no readmission for postoperative angina that would have required recatheterization in their first 50 patients after endoscopic RA harvesting at a 30-day follow-up. Yoshizaki and colleagues16
describe patent RA grafts in 5 patients who underwent endoscopic RA harvesting and postoperative angiography. In the series of Massetti and colleagues,17
15 of 15 RA grafts were patent postoperatively, also assessed by angiography. The perfect patency rate of 72% 1 year after endoscopic RA harvesting in our series seems comparable to patency rates after conventional RA harvest published in the literature; however, no randomized data are available. To explore whether the RA patency is influenced by the endoscopic technique, we compared our data with a retrospective control group of patients who underwent conventional open RA harvest during the same time period. We could not demonstrate a difference between perfect RA patency after endoscopic (72%) versus open RA harvest (74%, P = .822), whereas the 2 groups did not differ in baseline characteristics and target territories. Presumably, the use of the harmonic scalpel versus electrocautery may influence the patency more than the endoscopic or conventional technique. Endoscopic and conventional harvesting systems are available with the harmonic scalpel or with electrocautery. A study from Onorati and colleagues18
indicates better flowmetry and PI of the RA harvested with the harmonic scalpel versus electrocautery, whereas Cikirikcioglu and colleagues19
and Shapira and colleagues20
found no alterations in vasoreactivity or endothelial integrity for either technique.
Nevertheless, we had expected superior RA patency rates and thus aimed to identify factors influencing patency after endoscopic RA harvesting. Personnel factors such as the graft harvester or the graft implanting surgeon, as well as the learning curve, did not influence the RA patency. Furthermore, patient gender and age also did not influence the patency. Visible spasm of the RA after the harvest occurred in 1 case, and this graft was patent after 1 year. Intraoperatively assessed graft flow and PI tended to be better in RA grafts that were patent after 1 year, but this difference was not significant. It was not possible to evaluate a PI threshold value to predict graft occlusion. With regard to flow rate, grafts with a flow of less than 55 mL/min seemed to be more prone for occlusion (P = .007). Calcium-channel antagonists show proven antispasmodic effect on the RA,21
with dihydropyridine derivatives such as nifedipine or amlodipine being the most potent calcium antagonists. Therefore, we recommend the oral administration of amlodipine for at least 3 months after the operation. The length of amlodipine application (3 months or 1 year) did not correlate with RA patency in our series. Although the RA is more prone to vasoconstriction in the presence of norepinephrine,22
the postoperative amount of norepinephrine application did not affect RA patency as well. In our series, we could not demonstrate an impact of diabetes mellitus, smoking history, peripheral vessel disease, or hyperlipidemia on 1-year RA patency. This might be, at least in part, attributable to the low incidence of these risk factors in our patient population (Table 1). Also, the coronary territory to which the RA was anastomosed had no influence, which has also been described by Tatoulis and colleagues.23
In our cohort, the only significant and strong predictor of 1-year RA perfect patency was the severity of target vessel stenosis (Table 5). In the group of patients with a target vessel stenosis of 90% or greater, RA graft perfect patency was as high as 90.3% (28/31). With a target vessel stenosis of less than 90%, perfect patency was only 42% (8/19), indicating that RA grafts are prone to occlusion in the presence of competitive coronary flow. In our retrospective control group, this relation was also present, because perfect patency was 92% (22/24) in RA grafts anastomosed to target vessels with a stenosis of 90% or greater versus 58% (15/26) when target vessel stenosis was less than 90% (P = .006). In our series, this effect was distinct. Desai and colleagues24
speculate "that progressive auto-regulated adaptive narrowing of the RA conduit in the setting of competitive flow" may be the mechanism of graft occlusion. Royse and colleagues25
defined 70% coronary stenosis as a "cut-off" point. Below this degree of stenosis, the long-term patency of the RA was found to be significantly decreased. In accordance with our findings, Desai and associates4
described a significantly lower RA patency even when target vessel stenosis is less than 90% and recommend RA grafting to severely stenotic targets (>90%) to improve patency in a recent article.24
Fortunately, most of our patients with an occluded RA graft have no clinical symptoms, indicating that the rate of silent occlusion is high. Freedom from angina or dyspnea does not implicate RA graft patency.
In our cohort, the patency rates of LITA grafts (98%, 47/48) and RITA grafts (86%, 12/14) were satisfactory, whereas SV graft patency was less than expected (69%, 11/16). This may be because the SV was chosen as the graft of third choice after the LITA and a second arterial graft in this patient population.
| Conclusions |
|---|
|
|
|---|
| Limitations |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
B. F. Buxton, P. A. R. Hayward, A. E. Newcomb, S. Moten, S. Seevanayagam, and I. Gordon Choice of conduits for coronary artery bypass grafting: craft or science? Eur J Cardiothorac Surg, April 1, 2009; 35(4): 658 - 670. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Bisleri and C. Muneretto Endoscopic radial artery harvesting MMCTS, January 1, 2009; 2009(0907): mmcts.2008.003780 - mmcts.2008.003780. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bleiziffer, I. Hettich, B. Eisenhauer, D. Ruzicka, B. Voss, R. Bauernschmitt, and R. Lange Neurologic sequelae of the donor arm after endoscopic versus conventional radial artery harvesting J. Thorac. Cardiovasc. Surg., September 1, 2008; 136(3): 681 - 687. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Habib Optimal target vessel stenosis for radial artery grafting. J. Thorac. Cardiovasc. Surg., February 1, 2008; 135(2): 463 - 463. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |